Search

Search Constraints

You searched for: Author/Creator Litman, T.

Search Results

2. HSP90 inhibitor RGRN‐305 for oral treatment of plaque‐type psoriasis: efficacy, safety and biomarker results in an open‐label proof‐of‐concept study. (1st May 2022)

3. HSP90 inhibitor RGRN‐305 for oral treatment of plaque‐type psoriasis: efficacy, safety and biomarker results in an open‐label proof‐of‐concept study. (30th March 2022)